Best of the year: Advanced breast cancer in 2023

類似資料

• Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
  著者:: Semir Vranic
  出版事項: (2023-03-01)
• Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
  著者:: Roberta Caputo, 等
  出版事項: (2024-03-01)
• A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors
  著者:: Giuliana Pavone, 等
  出版事項: (2021-12-01)
• Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
  著者:: Yaping Zhang, 等
  出版事項: (2025-06-01)
• Cost-effectiveness of sacituzumab govitecan versus single-agent chemotherapy for metastatic triple-negative breast cancer: a trial-based analysis
  著者:: Yilai Wu, 等
  出版事項: (2024-04-01)